Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR

scientific article published on 26 September 2019

Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1084/JEM.20190111
P698PubMed publication ID31558613

P50authorBruce BeutlerQ104592
Haitao GuoQ87822141
Douglas T GolenbockQ89508853
Karen P McKinnonQ90316583
Jenny TingQ50858300
M DengQ83439399
P2093author name stringBeverly H Koller
Jason W Tam
W June Brickey
Brandon M Johnson
Hexin Shi
James S New
Austin Lenox
P2860cites workMutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndromeQ24291856
Targeting the NLRP3 inflammasome in inflammatory diseasesQ90350833
The NLRP3 inflammasome: molecular activation and regulation to therapeuticsQ91625115
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibitionQ92000897
IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infectionQ24302985
The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-betaQ24305136
NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorderQ24317771
AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCQ24319706
AIM2 activates the inflammasome and cell death in response to cytoplasmic DNAQ24319765
An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasomeQ24319799
Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptorQ24629279
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factorQ24679152
Inflammasomes: mechanism of action, role in disease, and therapeuticsQ27001186
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responsesQ27693180
Gout-associated uric acid crystals activate the NALP3 inflammasomeQ28131797
Differential activation of the inflammasome by caspase-1 adaptors ASC and IpafQ28266417
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretionQ28270330
Cryopyrin activates the inflammasome in response to toxins and ATPQ28291313
Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitisQ28345121
Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activationQ28387955
Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via IpafQ28506503
Non-canonical inflammasome activation targets caspase-11Q28506831
NLRP1-dependent pyroptosis leads to acute lung injury and morbidity in miceQ28508483
Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophagesQ28594887
Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant miceQ28609411
Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1Q29614473
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signalingQ29616024
The inflammasome NLRs in immunity, inflammation, and associated diseasesQ29616025
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitisQ29616155
Molecular identification of a danger signal that alerts the immune system to dying cellsQ29619497
K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matterQ29620146
Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cellsQ33289420
Platelet-activating factor and related lipid mediatorsQ33916020
Inflammatory caspases are innate immune receptors for intracellular LPS.Q34041730
The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP.Q34246151
Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factorQ35226480
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.Q35350543
A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome ActivationQ35836862
An NLRP7-containing inflammasome mediates recognition of microbial lipopeptides in human macrophagesQ35860827
Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and AktQ35929017
Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.Q36366486
Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptorQ36400935
Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptorsQ36503546
ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine wayQ36725685
NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome componentQ36888222
Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activationQ37143484
An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cellsQ37416793
NOX4-dependent fatty acid oxidation promotes NLRP3 inflammasome activation in macrophagesQ37548406
A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection.Q37741862
Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment ResponseQ37811988
NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutationsQ38750753
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling.Q38835006
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell deathQ38835009
Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasomeQ38985852
The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.Q39473693
NEK7 is an essential mediator of NLRP3 activation downstream of potassium effluxQ39607181
NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and -8.Q40250344
K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting MitochondriaQ40499822
Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasomeQ41574826
Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shockQ41970918
Localization and signaling of GPCRs in lipid raftsQ42489768
Defective NK cell activity and Th1 response in IL-18-deficient miceQ43595287
Noncanonical inflammasome activation by intracellular LPS independent of TLR4.Q44450840
The Inflammasome Drives GSDMD-Independent Secondary Pyroptosis and IL-1 Release in the Absence of Caspase-1 Protease ActivityQ47251504
The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages.Q47341459
CD36 and Platelet-Activating Factor Receptor Promote House Dust Mite Allergy DevelopmentQ47846762
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.Q48181308
Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome.Q51443610
The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in SepsisQ57457607
The NLRP6 Inflammasome Recognizes Lipoteichoic Acid and Regulates Gram-Positive Pathogen InfectionQ58605179
Platelet activating factor is produced during infectious peritonitis in CAPD patientsQ58831837
Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsisQ64127181
The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthmaQ72398982
Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responsesQ74139228
Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator GroupQ77754946
P433issue12
P304page(s)2838-2853
P577publication date2019-09-26
P1433published inJournal of Experimental MedicineQ3186912
P1476titlePlatelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR
P478volume216

Reverse relations

cites work (P2860)
Q97517003Dexmedetomidine Enhances Autophagy via α2-AR/AMPK/mTOR Pathway to Inhibit the Activation of NLRP3 Inflammasome and Subsequently Alleviates Lipopolysaccharide-Induced Acute Kidney Injury
Q91807444Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives
Q100444218Inflammasome Assays In Vitro and in Mouse Models
Q92188816Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination

Search more.